Clinical Trials Directory

Trials / Unknown

UnknownNCT03238508

Index of Microcirculatory Resistance After Immediate Versus Deferred Stenting in Patients With Acute Myocardial Infarction

Status
Unknown
Phase
Study type
Observational
Enrollment
60 (estimated)
Sponsor
Sejong General Hospital · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

This study will compare the microcirculatory resistance (IMR) of infarct-related artery (IRA) in patients who underwent immediate versus deferred stenting during percutaneous coronary intervention (PCI) for acute myocardial infarction.

Detailed description

Primary PCI with immediate stenting (IS) is the current standard of reperfusion strategy for STEMI. However, it is thought that IS may cause additional myocardial injury by increasing distal embolization of clot and atheromatous plaque debris. Only about 35% of patients without cardiogenic shock can achieve optimal myocardial tissue perfusion at the microvascular level, even after restoration of epicardial coronary artery patency. IS in highly pro-thrombotic and inflammatory milieu of IRA during primary PCI would increase distal embolization of clot and atheromatous plaque debris, and provoke the inflammation process, so deferred stenting after a cooling down period of IRA for several days, have a potential to mitigate or prevent microvascular obstruction (MVO). Among several methods to evaluate MVO after STEMI, IMR has been well known as an good indicator of MVO and strong predictor for short and long term clinical outcomes.

Conditions

Interventions

TypeNameDescription
PROCEDUREDeferred stentingPreviously described

Timeline

Start date
2013-01-01
Primary completion
2017-08-30
Completion
2017-09-30
First posted
2017-08-03
Last updated
2017-08-08

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT03238508. Inclusion in this directory is not an endorsement.